You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Obinutuzumab

Showing 26 - 50 of 177
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in China (Obinutuzumab, Glofitamab, Tocilizumab)

Recruiting
  • Lymphoma
  • Obinutuzumab
  • +2 more
  • Beijing, China
  • +6 more
Aug 4, 2022

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

Recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +5 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Apr 7, 2022

Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis Trial in Boston, Rochester, Philadelphia

Not yet recruiting
  • Granulomatosis With Polyangiitis
  • +2 more
  • Boston, Massachusetts
  • +2 more
Aug 2, 2022

Richter's Syndrome Trial in Israel (Obinutuzumab with Ibrutinib and Venetoclax)

Recruiting
  • Richter's Syndrome
  • Obinutuzumab with Ibrutinib and Venetoclax
  • Haifa, Israel
  • +3 more
Dec 6, 2021

Chronic Lymphocytic Leukemia Trial in Germany (Obinutuzumab, Venetoclax, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • +2 more
  • Bad Saarow, Germany
  • +29 more
May 4, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (RO7227166, Obinutuzumab, Glofitamab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Denver, Colorado
  • +13 more
Aug 19, 2022

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, CAL-101)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Apr 29, 2022

Lupus Nephritis, Systemic Lupus Erythematosus (SLE) Trial in Paris (Obinutuzumab administration, Administration of

Recruiting
  • Lupus Nephritis
  • Systemic Lupus Erythematosus (SLE)
  • Obinutuzumab administration
  • +2 more
  • Paris, France
    Internal medicine, Cochin hospital, APHP
Dec 9, 2021

Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 1

Active, not recruiting
  • Ann Arbor Stage II Grade 1 Follicular Lymphoma
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus (drug, biological, other)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Bcl-2 Inhibitor GDC-0199
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 29, 2021

Lymphoma, Non-Hodgkin Trial in Mainz (Obinutuzumab and Pixantrone)

Completed
  • Lymphoma, Non-Hodgkin
  • Obinutuzumab and Pixantrone
  • Mainz, RLP, Germany
    Department of Hematology, Oncology and Pneumology; University Me
Mar 30, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Austria (Venetoclax, Obinutuzumab)

Completed
  • Lymphoma, Large B-Cell, Diffuse
  • Graz, Austria
  • +5 more
Feb 15, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Acalabrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Aug 9, 2021

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in Atlanta (drug, biological,

Recruiting
  • Grade 1 Follicular Lymphoma
  • +7 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 7, 2021

Marginal Zone Lymphoma Trial in Germany (Obinutuzumab)

Recruiting
  • Marginal Zone Lymphoma
  • Obinutuzumab
  • Bochum, Germany
  • +15 more
Mar 14, 2022

CLL Trial in La Jolla (GA101/HDMP)

Active, not recruiting
  • CLL
  • La Jolla, California
    UCSD Moores Cancer Center
Sep 2, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Acalabrutinib, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Basking Ridge, New Jersey
  • +7 more
Aug 1, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Cyclophosphamide, Fludarabine Phosphate, Ibrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2022

Lymphoma, Non-Hodgkin's Trial in Toronto (Obinutuzumab, Gemcitabine, Dexamethasone)

Completed
  • Lymphoma, Non-Hodgkin's
  • Obinutuzumab
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2021

Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

Active, not recruiting
  • Hairy Cell Leukemia
  • +2 more
  • New Haven, Connecticut
  • +8 more
Feb 7, 2022

CNS B-Cell Non-Hodgkin Lymphoma Trial in United States (procedure, biological, other)

Recruiting
  • Central Nervous System B-Cell Non-Hodgkin Lymphoma
  • Cognitive Assessment
  • +2 more
  • Denver, Colorado
  • +11 more
Jun 9, 2022

Chronic Lymphocytic Leukemia, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

B-cell Lymphoid Malignancies Trial in Australia, Korea, Republic of, United States (Zanubrutinib, Obinutuzumab)

Completed
Has Results
  • B-cell Lymphoid Malignancies
  • Fort Myers, Florida
  • +14 more
Mar 1, 2022

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in France, Italy, Netherlands (Obinutuzumab, CC-122)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Borddeaux Cedex, France
  • +7 more
Oct 25, 2021

NSCLC Trial in United States (NAP (Naptumomab estafenatox), Docetaxel, Obinutuzumab)

Recruiting
  • Non-small Cell Lung Cancer
  • NAP (Naptumomab estafenatox)
  • +2 more
  • Daphne, Alabama
  • +9 more
Oct 20, 2021